BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Deals

Cephalon, ImmunGene deal

Cephalon's Cephalon Australia Pty. Ltd. subsidiary partnered with ImmunGene to apply ImmunGene's interferon payload drug delivery technology to up to six of Cephalon's cancer drug...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >